Toxoplasmosis initially presenting as neurological sequelae of chimeric antigen receptor T-cell therapy

Lancet Infect Dis. 2019 Jul;19(7):788. doi: 10.1016/S1473-3099(19)30119-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Cognitive Dysfunction / etiology
  • Humans
  • Immunotherapy, Adoptive / adverse effects*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Middle Aged
  • Muscle Weakness / etiology
  • Neuroimaging
  • Neurotoxicity Syndromes
  • Pyrimethamine / administration & dosage*
  • Toxoplasmosis, Cerebral / diagnosis*
  • Toxoplasmosis, Cerebral / drug therapy*

Substances

  • Pyrimethamine